- A Danish study found statin use after type 2 diabetes diagnosis was associated with lower dementia risk.
- Starting statins within one year was linked with a 15% lower relative risk over 10 years.
- The study cannot prove statins prevent dementia, but it strengthens the case for timely cholesterol management.
People with type 2 diabetes are already advised to manage cholesterol carefully.
That advice is usually framed around preventing heart attacks and strokes.
A new Danish study suggests there may also be a brain-health angle.
Researchers looked at 132,585 people who developed type 2 diabetes between 2006 and 2019 and had not previously used statins.
They compared dementia outcomes in people who did not start statins, those who started within one year and those who started between one and five years after diagnosis.
During a median follow-up of 7.1 years, 2.7% of patients developed dementia.
Compared with no statin initiation, early statin use was associated with a 15% lower relative risk of dementia over 10 years.
Later statin use was linked with a 10% lower relative risk.
The pattern was similar in women and men.
This does not prove statins directly prevent dementia.
The researchers used methods designed to reduce bias, but this remains an observational study.
People who start statins earlier may differ from those who do not in ways that are difficult to measure fully.
Even so, the finding is plausible.
Type 2 diabetes, high LDL cholesterol and vascular disease are all linked with cognitive decline.
The brain depends on healthy blood vessels.
If statins reduce vascular injury over time, it is not surprising that dementia risk might shift too.
The useful point is timing.
- Better cardiorespiratory fitness linked to lower risk of dementia, depression and psychosis
- Cooking at home may help lower dementia risk in older adults
The association was stronger when statins were started within one year of type 2 diabetes diagnosis.
That suggests cholesterol management should not be treated as an optional add-on years later.
For people in the UK, this is a conversation to have with a GP, diabetes nurse or pharmacist.
Statins are not suitable for everyone, and side effects need to be taken seriously.
But for many people with type 2 diabetes, they remain one of the most evidence-based tools for reducing cardiovascular risk.
This study suggests the benefits may extend further than the heart.
Study link: Association between timing of statin treatment after diabetes diagnosis and risk of dementia
